|Day Low/High||37.61 / 38.31|
|52 Wk Low/High||24.30 / 45.43|
Electro Scientific Industries leads a parade of value stocks that have performed quite nicely in a growth-oriented market.
Despite the disparity this year between growth and value, my 2017 Double Net Value Portfolio is not struggling.
Double-Net Dividend stocks, which some would call misfits, doing OK so far.
Buying's good for the acquirers, which should give other companies ideas.
Just two months after its creation, the portfolio handily is beating the Russell 2000 Index and Russell Microcap Index.
'Double-nets' have been fertile ground for acquisitions.
The list is dominated by retailers, of which there are four; that's unfortunate, given the pressure that sector is facing these days.
An eclectic mix of 20 companies made my cut of stocks trading at 1x to 2x net current asset value.
The electronic components name that recently bought Premier Farnell is undergoing a noteworthy transition.
Checking the gauges for underperformance, none of them look good.
This is what matters in making more money for your portfolio.
Jim Cramer, The Street's Action Alerts PLUS Portfolio Manager and host of CNBC's 'Mad Money,' said Allergan (AGN) is a stock to hold onto.
These stocks have seen such spikes in concert with price compression, which tends to amplify volatility.
The EU recovery has put heavily exposed U.S. techs and industrials in an enviable position.
Dan Fitzpatrick, founder of StockMarketMentor.com, details three stocks Jim Cramer discussed on CNBC's "Mad Money" and how to trade them.
As we have seen time and again, weakness really is a buying opportunity.